Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-Center, Double-Blinded, Placebo-Controlled Trial to Evaluate the Effectiveness of Patent Foramen Ovale Closure With the BioSTAR Septal Repair Implant to Reduce Refractory Migraine Headache With Aura.

NCT00283738 is registered in ClinicalTrials.gov with NMT Medical as lead sponsor.

NCT NCT00283738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00283738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-Center, Double-Blinded, Placebo-Controlled Trial to Evaluate the Effectiveness of Patent Foramen Ovale Closure With the BioSTAR Septal Repair Implant to Reduce Refractory Migraine Headache With Aura.
Lead sponsor
NMT Medical
Phase
Phase 2/3
Overall status
Unknown status
Start date
February 28, 2006
Completion date
March 31, 2008
Enrollment
610 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

aura, migraine, patent foramen ovale